News
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited...
Read moreOffers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to...
Read moreSince the introduction of routine rotavirus vaccination in 2006, rates of diarrhea-related hospitalizations in US children have decreased significantly. ...
Read moregenOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists Lyon, France,...
Read moreBoehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the company has decided not to...
Read moreBritons can now get a quick HIV test — in 60 seconds flat, when they visit a supermarket. A British...
Read moreThe takeover drama of Britain's AstraZeneca by US drugs giant Pfizer has now reached British prime minister David Cameron's doorstep. In...
Read morePfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also...
Read morePar Pharmaceutical Companies, Inc. today issued the following statement in response to inquiries it has received regarding the potential use...
Read moreThe US crackdown on healthcare fraud is paying huge dividends to the exchequer, accounting for three quarters of the money...
Read more
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.